COVID-19 lab score, a dynamic tool to predict related mortality risk | All the latest medical news on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

COVID-19 lab score, a dynamic tool to predict related mortality risk

COVID-19 lab score, a dynamic tool to predict related mortality risk COVID-19 lab score, a dynamic tool to predict related mortality risk
COVID-19 lab score, a dynamic tool to predict related mortality risk COVID-19 lab score, a dynamic tool to predict related mortality risk

What's new?

The COVID-19 lab score is a simple and accurate tool to forecast in-hospital outcomes in coronavirus-infected individuals.

As per the findings from a study published in “Scientific Reports”, the COVID-19 lab score can readily estimate mortality risk in hospitalized patients infected with coronavirus disease (COVID-19). Researchers carried out this retrospective, multicentre, observational study to determine the laboratory predictors of mortality in coronavirus infection that can aid to identify high-risk patients.

The study recruited all individuals (n=893, median age 68.2 ± 15.2 years) admitted to the hospital due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The laboratory biomarkers that contributed with considerable predictive value for estimating mortality to the clinical model were incorporated. The cut-off points were established, and the creation of a risk score was done. 

In total, 87 (9.7%) subjects were hospitalized to the intensive care unit, 72 (8.1%) subjects required mechanical ventilation support, and 171 (19.1%) subjects died. Based on the multivariate logistic regression model, a COVID-19 lab score ranging from 0 to 30 points was determined to estimate mortality with a weighted score. It included D-dimer, C-reactive protein, haemoglobin, lymphocytes, interleukin-6, erythrocytes, lactate dehydrogenase, leukocytes, neutrophils, creatinine, and procalcitonin.

The participants were segregated into low mortality risk group (less than 12 points),  moderate risk (12-18 points), and high-risk group (19 or more points). Substantial mortality differences were noted between the groups, as shown in the figure below:


The C-statistic was found to be 0–85 (0.82–0.88) while the Hosmer–Lemeshow p-value was 0.63. Thus, the COVID-19 lab score, a simple and dynamic score, can be easily replicated. It could aid healthcare professionals to accurately assess the risk of adverse outcomes, and also recognize high-risk patients to foresee clinical deterioration. 

Source:

Scientific Reports

Article:

The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients

Authors:

Pablo Jose Antunez Muiños et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: